当前位置:产品中心>单抗/多抗

Anti-Human CD278/ICOS & PD-1 Bispecific Reference Antibody|抗人CD278/ICOS和PD-1双特异性参考抗体(靶标:人ICOS/PD-1)

货号:RB9T37015459
  • 价格:面议
  • 点击数:566
  

产品介绍

产品参数

形态Liquid
宿主种属Humanized
克隆性Monoclonal
抗体亚型half-IGG1-kappa/(scFv-kappa-heavy)-h-CH2-CH3
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标CD278, ICOS, Inducible T-cell costimulator, Activation-inducible lymphocyte immunomediatory molecule, AILIM, Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号Q9Y6W8 & Q15116
背景信息Izuralimab is a bispecific IgG1 antibody targeting inducible T-cell costimulator (ICOS/CD278) and PD-1.<br>
别名Bispecific, XmAb-23104, 2329669-80-7
备注For research use only. Not suitable for clinical or therapeutic use.